Immunomedics

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer and other serious diseases. Immunomedics? corporate objective is to become a fully-integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates. Mission: We will become a leading and integrated biopharmaceutical company dedicated to building, developing and commercializing a highly differentiated portfolio of targeted biologic therapies to transform patient outcomes based on clinical data and the deep scientific understanding of select solid tumor cancers and hematologic malignancies.